approved

Приложение 4 на ПЛС от 02.08.2020 г.

Unique identificator:  4cf24e0d-723c-4ee6-8f1f-85079e7c20cf

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-08-06 16:31:04
  • Created by: georgi_sivchev
  • Updated at: 2020-08-06 16:31:04
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Propafenone 20020603 Rytmonorm, Film coated tablet, 150, mg, Pack: 30 Mylan Healthcare GmbH, Германия AbbVie Deutschland GmbH&Co KG, Германия; Famar Lyon 29 Avenue Charles de Gaulle 69230 Saint-Genis Laval, Франция 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 промяна на обстоятелства НСР-3647/29.05.2014; НСР-3794/16.06.2014; НСР-7877/25.01.2016; НСР-8187/22.02.2016; КЦРР-561/04.05.2012 23.05.2012 23.05.2012 Неактивен 1208
Propafenone II-0942/24.10.2007 Rytmonorm, Film coated tablet, 150, mg, Pack: 30 Abbott GmbH & Co KG, Германия Abbott GmbH&CoKG, Knollstrasse 50, Ludwigshafen Германия 5.83 1.17 7 9% 0.52 6.35 1.27 7.62 22% 1.28 7.63 1.53 9.16 КЦ-453/21.01.2009 12.02.2009 12.02.2009 Неактивен 1208
Propafenone 20020602 Rytmonorm, Film coated tablet, 300, mg, Pack: 20 Майлан ЕООД, България AbbVie Deutschland GmbH&Co KG, Германия; Famar Lyon 29 Avenue Charles de Gaulle 69230 Saint-Genis Laval, Франция 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 промяна на обстоятелства НСР-3650/29.05.2014; НСР-3792/16.06.2014; НСР-7876/25.01.2016; НСР-8188/22.02.2016; НСР-19554/14.08.2019 КЦРР-561/04.05.2012 23.05.2012 02.09.2019 Активен 1209
Propafenone 20020602 Rytmonorm, Film coated tablet, 300, mg, Pack: 20 Mylan Healthcare GmbH, Германия AbbVie Deutschland GmbH&Co KG, Германия; Famar Lyon 29 Avenue Charles de Gaulle 69230 Saint-Genis Laval, Франция 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 промяна на обстоятелства НСР-3650/29.05.2014; НСР-3792/16.06.2014; НСР-7876/25.01.2016; НСР-8188/22.02.2016 КЦРР-561/04.05.2012 23.05.2012 23.05.2012 Неактивен 1209
Propafenone II-0943/24.10.2007 Rytmonorm, Film coated tablet, 300, mg, Pack: 20 Abbott GmbH & Co KG, Германия Abbott GmbH&CoKG, Knollstrasse 50, Ludwigshafen Германия 7.75 1.55 9.3 9% 0.7 8.45 1.69 10.14 22% 1.71 10.16 2.03 12.19 КЦ-453/21.01.2009 12.02.2009 12.02.2009 Неактивен 1209
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 60 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 293.68 58.74 352.42 4% 10 303.68 60.74 364.42 16% 25 328.68 65.74 394.42 НСР-11881/06.03.2017; НСР-18805/30.05.2019 14.06.2019 02.07.2019 Активен 15622
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 60 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 488.96 97.79 586.75 4% 10 498.96 99.79 598.75 16% 25 523.96 104.79 628.75 НСР-11881/06.03.2017 21.03.2017 02.04.2017 Неактивен 15622
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 77.26 15.45 92.71 4% 3.09 80.35 16.07 96.42 16% 12.36 92.71 18.54 111.25 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение); КП-20/11.04.2017 и НСР-11215/15.12.2016; НСР-14042/02.10.2017 02.05.2017 02.11.2017 Заличен 4214
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 77.26 15.45 92.71 4% 3.09 80.35 16.07 96.42 16% 12.36 92.71 18.54 111.25 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение); КП-20/11.04.2017 и НСР-11215/15.12.2016 02.05.2017 02.05.2017 Неактивен 4214
Rasagiline 20160015 Sagilia, Tablet, 1, mg, Pack: 30 Medochemie Ltd., Кипър Medochemie Ltd., Factory AZ, Limassol, Кипър 122.45 24.49 146.94 4% 4.9 127.35 25.47 152.82 16% 19.59 146.94 29.39 176.33 НСР-8539/24.03.2016 и НСР-8660/01.04.2016 (допуска предварително изпълнение) 02.04.2016 02.04.2016 Неактивен 4214
Sulfasalazine II-4492/18.03.2009 SALAZOPYRIN EN, Gastro resistant tablet, 500, mg, Pack: 100 Pfizer Enterprises SARL, Люксембург Kemwell AB - Sweden 9.31 1.86 11.17 7% 0.65 9.96 1.99 11.95 20% 1.86 11.82 2.36 14.18 Цената се заличава с решение НСР-3790/16.06.2014 ( в сила от 16.07.2014) КЦРР-2203/06.02.2013 03.03.2013 03.03.2013 Заличен 1652
Sulfasalazine II-4492/18.03.2009 SALAZOPYRIN EN, Gastro resistant tablet, 500, mg, Pack: 100 Pfizer Enterprises SARL, Люксембург Kemwell AB - Sweden 13.2 2.64 15.84 6% 0.79 13.99 2.8 16.79 18% 2.38 16.37 3.27 19.64 КЦ-826/15.04.2009 30.04.2009 30.04.2009 Неактивен 1652
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 GlaxoSmithKline (Ireland) Limited, Ирландия Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.8 0.56 3.36 7% 0.2 3 0.6 3.6 20% 0.56 3.56 0.71 4.27 Промяна на обстоятелства НСР-18242/22.03.2019 НСР-2429/21.01.2014; НСР-12563/05.05.2017; НСР-15953/22.06.2018 07.07.2018 02.05.2019 Активен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.8 0.56 3.36 7% 0.2 3 0.6 3.6 20% 0.56 3.56 0.71 4.27 НСР-2429/21.01.2014; НСР-12563/05.05.2017; НСР-15953/22.06.2018 07.07.2018 02.08.2018 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 2.99 0.6 3.59 7% 0.21 3.2 0.64 3.84 20% 0.6 3.8 0.76 4.56 НСР-2429/21.01.2014; НСР-12563/05.05.2017 20.05.2017 02.06.2017 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 3.13 0.63 3.76 7% 0.22 3.35 0.67 4.02 20% 0.63 3.98 0.8 4.78 НСР-2429/21.01.2014 05.02.2014 05.02.2014 Неактивен 2452
Salbutamol 20030690 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 КЦРР-2665/20.03.2013 19.04.2013 19.04.2013 Неактивен 2452
Salbutamol II-6771/12.02.2010 SALBUTAMOL INHALER, Pressurised inhalation, suspension, 100 mcg/metered actuation - 200 doses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France; GlaxoSmithKline Pharmaceuticals SA, Poland; Glaxo Wellcome S.A., Spain 3.89 0.78 4.67 7% 0.27 4.16 0.83 4.99 20% 0.78 4.94 0.99 5.93 КЦ-1683/25.06.2010 15.07.2010 15.07.2010 Неактивен 2452
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.89 0.58 3.47 7% 0.2 3.09 0.62 3.71 20% 0.58 3.67 0.73 4.4 НСР-1636/11.11.2013; НСР-11770/17.02.2017; НСР-18772/21.05.2019; НСР-20729/30.01.2020 05.06.2019 02.03.2020 Заличен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.89 0.58 3.47 7% 0.2 3.09 0.62 3.71 20% 0.58 3.67 0.73 4.4 НСР-1636/11.11.2013; НСР-11770/17.02.2017; НСР-18772/21.05.2019 05.06.2019 02.07.2019 Неактивен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 2.97 0.59 3.56 7% 0.21 3.18 0.64 3.82 20% 0.59 3.77 0.75 4.52 НСР-1636/11.11.2013; НСР-11770/17.02.2017 04.03.2017 02.04.2017 Неактивен 2246
Salbutamol 20110698 Salbutamol Sandoz, Pressurised inhalation, suspension, 100 mcg/dose - 200 doses, mg, Pack: 1 Sandoz d.d., Словения Aeropharm GmbH, Francois – Mitterrand-Allee 1, 07407 Rudolstadt, Германия 3.19 0.64 3.83 7% 0.22 3.41 0.68 4.09 20% 0.64 4.05 0.81 4.86 НСР-1636/11.11.2013 26.11.2013 26.11.2013 Неактивен 2246
Salmeterol, Fluticasone 20170120 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/250 mcg, -, Pack: 120 doses Cipla Europe NV, Белгия S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 35.2 7.04 42.24 4% 1.41 36.61 7.32 43.93 16% 5.63 42.24 8.45 50.69 Промяна на обстоятелства НСР-19751/04.09.2019 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2019 Активен 16271
Salmeterol, Fluticasone 20170120 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/250 mcg, -, Pack: 120 doses Cipla (UK) Ltd., Обединено Кралство S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 35.2 7.04 42.24 4% 1.41 36.61 7.32 43.93 16% 5.63 42.24 8.45 50.69 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2018 Неактивен 16271
Salmeterol, Fluticasone 20170119 Salmeterol and fluticasone Cipla, Pressurised inhalation, suspension, 25 mcg/125 mcg, -, Pack: 120 doses Cipla Europe NV, Белгия S&D Pharma CZ, spol. s r.o, Чешка Република; Cipla (EU) Ltd, Обединено Кралство; Cipla Europe NV, Белгия 27.83 5.57 33.4 6% 1.67 29.5 5.9 35.4 18% 5.01 34.51 6.9 41.41 Промяна на обстоятелства НСР-19751/04.09.2019 НСР-15801/08.06.2018; корекционно решение НСР-16098/05.07.2018; Прот. № 280/30.05.2018 12.09.2018 02.10.2019 Активен 16272
Showing 13626 to 13651 of 17770 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте